128
Views
30
CrossRef citations to date
0
Altmetric
Review

Epigenetic biomarkers in urothelial bladder cancer

&
Pages 259-269 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sarmistha Talukdar, Luni Emdad, Swadesh K Das, Devanand Sarkar & Paul B Fisher. (2015) Noninvasive approaches for detecting and monitoring bladder cancer. Expert Review of Anticancer Therapy 15:3, pages 283-294.
Read now
Hong Chen, Yang Yu, Shuang Rong & Hongyan Wang. (2014) Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a systematic review and meta-analysis. Biomarkers 19:3, pages 189-197.
Read now
Mariana Brait, Enrico Munari, Cynthia LeBron, Maartje G. Noordhuis, Shahnaz Begum, Christina Michailidi, Nilda Gonzalez-Roibon, Leonel Maldonado, Tanusree Sen, Rafael Guerrero-Preston, Leslie Cope, Paola Parrella, Vito Michele Fazio, Patrick K. Ha, George J. Netto, David Sidransky & Mohammad O. Hoque. (2013) Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle 12:7, pages 1058-1070.
Read now
Ana Isabel Oliveira, Carmen Jerónimo & Rui Henrique. (2012) Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers. Expert Review of Molecular Diagnostics 12:8, pages 871-878.
Read now

Articles from other publishers (26)

Qixun Fang, Xu Zhang, Qing Nie, Jianqiang Hu, Shujun Zhou & Chaojun Wang. (2022) Improved urine DNA methylation panel for early bladder cancer detection. BMC Cancer 22:1.
Crossref
Yufeng Guo, Jianjian Yin, Yuanheng Dai, Yudong Guan, Pinjin Chen, Yongqiang Chen, Chenzheng Huang, Yong-Jie Lu, Lirong Zhang & Dongkui Song. (2021) A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Kiran Tripathi, Apul Goel, Atin Singhai & Minal Garg. (2021) Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder. Molecular Biology Reports 48:3, pages 2183-2199.
Crossref
Jayoung Kim, Won Tae Kim & Wun-Jae Kim. (2020) Advances in urinary biomarker discovery in urological research. Investigative and Clinical Urology 61:Suppl 1, pages S8.
Crossref
Yinghui Yu, Hui Cao, Mengmeng Zhang, Fang Shi, Rui Wang & Xin Liu. (2018) Prognostic value of DNA methylation for bladder cancer. Clinica Chimica Acta 484, pages 207-212.
Crossref
Inês Faleiro, Ricardo Leão, Alexandra Binnie, Ramon Andrade de Mello, Ana-Teresa Maia & Pedro Castelo-Branco. (2016) Epigenetic therapy in urologic cancers: an update on clinical trials. Oncotarget 8:7, pages 12484-12500.
Crossref
HYUNG-YOON YOON, YONG-JUNE KIM, JI SANG KIM, YOUNG-WON KIM, HO WON KANG, WON TAE KIM, SEOK-JOONG YUN, KEUN HO RYU, SANG-CHEOL LEE & WUN-JAE KIM. (2016) RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer. Oncology Reports 35:2, pages 1195-1203.
Crossref
Yong-June KimWun-Jae Kim. (2016) Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?. Investigative and Clinical Urology 57:Suppl 1, pages S77.
Crossref
Hyung-Yoon Yoon, Sung Pil Seo, Sang Keun Lee, Ho Won Kang, Won Tae Kim, Dong Hee Ryu, Seok-Joong Yun, Sang-Cheol Lee, Wun-Jae Kim & Yong-June Kim. (2015) Association of GATA5 methylation with clinocopathological characteristics in non-muscle invasive bladder cancer. Journal of Biomedical Research 16:4, pages 146-151.
Crossref
Matthew K. Medeiros & A. Jay Gandolfi. 2015. Arsenic. Arsenic 163 191 .
Young-Won Kim, Hyung-Yoon Yoon, Sung Pil Seo, Sang Keun Lee, Ho Won Kang, Won Tae Kim, Heui Je Bang, Dong Hee Ryu, Seok-Joong Yun, Sang-Cheol Lee, Wun-Jae Kim & Yong-June Kim. (2015) Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer . Disease Markers 2015, pages 1-6.
Crossref
Margaret A. Knowles & Carolyn D. Hurst. (2014) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nature Reviews Cancer 15:1, pages 25-41.
Crossref
Pia Antony, Michael Rose, Axel Heidenreich, Ruth Knüchel, Nadine T Gaisa & Edgar Dahl. (2014) Epigenetic inactivation of ST6GAL1 in human bladder cancer. BMC Cancer 14:1.
Crossref
Sheng-Fang Su, André Luís de Castro Abreu, Yoshitomo Chihara, Yvonne Tsai, Claudia Andreu-Vieyra, Siamak Daneshmand, Eila C. Skinner, Peter A. Jones, Kimberly D. Siegmund & Gangning Liang. (2014) A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence. Clinical Cancer Research 20:7, pages 1978-1989.
Crossref
Yong-June Kim, Hyung-Yoon Yoon, Ji Sang Kim, Ho Won Kang, Byung-Dal Min, Seon-Kyu Kim, Yun-Sok Ha, Isaac Yi Kim, Keun Ho Ryu, Sang-Cheol Lee & Wun-Jae Kim. (2013) HOXA9 , ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array-based DNA methylation and expression profiling . International Journal of Cancer 133:5, pages 1135-1142.
Crossref
Kelly H. Telu, Besma Abbaoui, Jennifer M. Thomas-Ahner, Debra L. Zynger, Steven K. Clinton, Michael A. Freitas & Amir Mortazavi. (2013) Alterations of Histone H1 Phosphorylation During Bladder Carcinogenesis. Journal of Proteome Research 12:7, pages 3317-3326.
Crossref
Hyung-Yoon YoonYoung-Won KimHo Won KangWon Tae KimSeok-Joong Yun, Sang-Cheol LeeWun-Jae KimYong-June Kim. (2013) Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer . Korean Journal of Urology 54:3, pages 194.
Crossref
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology 707 733 .
Marta Sánchez-Carbayo. (2012) Hypermethylation in bladder cancer: biological pathways and translational applications. Tumor Biology 33:2, pages 347-361.
Crossref
Ying-Li Lin, Xiao-Qiang Liu, Wen-Ping Li, Guang Sun & Chun-Ting Zhang. (2011) Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma. International Urology and Nephrology 44:1, pages 111-117.
Crossref
Hyung-Yoon YoonYoung-Won KimHo-Won KangWon Tae KimSeok-Joong Yun, Sang-Cheol LeeWun-Jae KimYong-June Kim. (2012) DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis . Korean Journal of Urology 53:3, pages 200.
Crossref
Wun-Jae Kim & Yong-June Kim. 2012. Cancer Epigenetics. Cancer Epigenetics 111 118 .
Liang Cheng, Shaobo Zhang, Gregory T. MacLennan, Sean R. Williamson, Antonio Lopez-Beltran & Rodolfo Montironi. (2011) Bladder cancer: translating molecular genetic insights into clinical practice. Human Pathology 42:4, pages 455-481.
Crossref
YL Lin, G Sun, XQ Liu, WP Li & JG Ma. (2011) Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma . Journal of International Medical Research 39:1, pages 179-186.
Crossref
Peter H RoosNorbert Jakubowski. (2010) Methods for the discovery of low-abundance biomarkers for urinary bladder cancer in biological fluids. Bioanalysis 2:2, pages 295-309.
Crossref
Frank McCaughan & Paul H Dear. (2010) Single-molecule genomics. The Journal of Pathology 220:2, pages 297-306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.